Why US Healthcare Is So Broken

Video Description

📚 Review our sources ► https://pastebin.com/mjv7kXKV 💻 Check out our website, newsletter, and more ► linktr.ee/2and20 ✋ Get in touch ► [email protected] See how the media is shaping stories worldwide with Ground News. Head over to https://check.ground.news/2and20 to delve into diverse perspectives and get a 15% discount on unlimited access when you use our link. The US spends more on healthcare than any other country, yet Americans visit doctors less often and have lower life expectancy than other wealthy nations. How did the world’s most advanced economy end up with such a broken healthcare system? In this video, we explore the complexities of US healthcare, revealing how insurance companies, healthcare providers, and pharmaceutical giants prioritize profits over patients. From rising administrative costs to insurance claim denials, physician shortages, and outrageous drug pricing, the system is riddled with inefficiencies and greed. We begin with the dark realities of health insurance—where 40% of hospital expenses are tied to administration, and claim denials have surged by over 50%. Next, we uncover how doctor shortages were intentionally created, driving up physician salaries and consolidating hospital groups. Finally, we examine the pharmaceutical industry, which charges Americans far more than the rest of the world for the same drugs, while engaging in ethically questionable practices. This isn’t just a story of high costs; it’s a story of lives impacted by a system designed to prioritize corporate interests over public well-being. Despite the US having world-class technology and top medical professionals, access to this quality care remains elusive for the average American. Join us as we ask: Is greed always good? Can the US learn from other nations and build a system that works for everyone? 🔔 Don’t forget to subscribe to 2&20 for more deep dives into economics, politics, and policy. 00:00 - Intro 01:41 - Health Insurance 08:51 - Healthcare Providers 14:09 - Pharma 18:21 - Conclusion